Achieve Life Sciences, Inc. - Common Shares (ACHV) earnings
ACHV earnings moved a median of -1.02% by the close. Quarterly and annual ACHV reports and results, each read against the price at its own news timestamp. Back to the ACHV overview →
24 measured ACHV earnings events.
Where these ACHV earnings landedvs 24 measured ACHV earnings reactions
| Middle 50% of ACHV earnings reactions | -2.58% to +2.12% |
|---|---|
| Median reaction (to close) | -1.02% |
| Measured reactions | 24 |
Point-in-time · zero look-ahead
Half of the 24 ACHV earnings events with a measured close landed between -2.58% and +2.12%; 38% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates | Press release | +0.97% | +2.89% | |
| Form 10-Q ACHIEVE LIFE SCIENCES, For: Jun 30 | SEC filing · Form 10-Q | -0.67% | -1.18% | |
| Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates | Press release | +3.74% | +11.96% | |
| Form 10-Q ACHIEVE LIFE SCIENCES, For: Mar 31 | SEC filing · Form 10-Q | +3.74% | +11.96% | |
| Achieve Life Sciences to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2026 | Press release | -0.11% | +3.64% | |
| Form 10-K/A ACHIEVE LIFE SCIENCES, For: Dec 31 | SEC filing · Form 10-K | -1.59% | -0.23% | |
| Form 10-K ACHIEVE LIFE SCIENCES, For: Dec 31 | SEC filing · Form 10-K | -1.64% | -20.77% | |
| Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program | Press release | -0.71% | -4.43% | |
| Form 10-Q ACHIEVE LIFE SCIENCES, For: Sep 30 | SEC filing · Form 10-Q | -0.71% | -4.43% | |
| Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program | Press release | +1.11% | -2.58% | |
| Form 10-Q ACHIEVE LIFE SCIENCES, For: Jun 30 | SEC filing · Form 10-Q | +1.11% | -2.58% | |
| Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program | Press release | -1.37% | +3.52% | |
| Form 10-Q ACHIEVE LIFE SCIENCES, For: Mar 31 | SEC filing · Form 10-Q | -1.37% | +3.52% | |
| Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025 | Press release | +0.76% | -5.53% | |
| Form 10-K ACHIEVE LIFE SCIENCES, For: Dec 31 | SEC filing · Form 10-K | -2.30% | -3.95% | |
| Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update | Press release | +0.42% | -2.11% | |
| Form 10-Q ACHIEVE LIFE SCIENCES, For: Sep 30 | SEC filing · Form 10-Q | +0.42% | -2.11% | |
| Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate Update | Press release | +2.09% | +1.86% | |
| Form 10-Q ACHIEVE LIFE SCIENCES, For: Jun 30 | SEC filing · Form 10-Q | +2.09% | +1.86% | |
| Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update | Press release | +0.65% | -0.86% | |
| Form 10-Q ACHIEVE LIFE SCIENCES, For: Mar 31 | SEC filing · Form 10-Q | +0.65% | -0.86% | |
| Form 10-K ACHIEVE LIFE SCIENCES, For: Dec 31 | SEC filing · Form 10-K | -3.56% | -1.29% | |
| Form 10-Q ACHIEVE LIFE SCIENCES, For: Sep 30 | SEC filing · Form 10-Q | +1.68% | -1.44% | |
| Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023 | Press release | -0.75% | +0.75% |
Keep exploring
More ACHV: analyst actions → · SEC filings → · ACHV overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Sutro Biopharma, Inc. (STRO) | 271 | -0.56% | 41% |
| PRESBIA PLC ORDINARY SHARES (LENS) | 270 | 0.00% | 42% |
| CorMedix Inc. (CRMD) | 269 | -0.42% | 39% |
| Verrica Pharmaceuticals Inc. (VRCA) | 269 | -0.01% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.